Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy.
Amna ParveenJin Hyun KimByeong Gyu OhLalita SubediZahra KhanSun Yeou KimPublished in: Molecules (Basel, Switzerland) (2018)
Background: A variety of causative factors are involved in the initiation of diabetic retinopathy (DR). Current antidiabetic therapies are expensive and not easily accessible by the public. Furthermore, the use of multiple synthetic drugs leads to severe side effects, which worsen the diabetic patient’s condition. Medicinal plants and their derived phytochemicals are considered safe and effective treatment and their consumption can reduce the DR risk. In this article, we discuss a variety of medicinal plants, and their noteworthy bio-active constituents, that will be utilized as target based therapeutic strategies for DR. Methods: A broad-spectrum study was conducted using published English works in various electronic databases including Science Direct, PubMed, Scopus, and Google Scholar. Results: Targeting the multiple pathological factors including ROS, AGEs formation, hexosamine flux, PARP, PKC, and MAPK activation through variety of bioactive constituents in medicinal plants, diabetes progression can be delayed with improved loss of vision. Conclusions: Data reveals that traditional herbs and their prominent bioactive components control and normalize pathological cellular factors involved in DR progression. Therefore, studies should be carried out to explore the protective retinopathy effects of medicinal plants using experimental animal and humans models.
Keyphrases
- diabetic retinopathy
- editorial comment
- optical coherence tomography
- type diabetes
- dna damage
- signaling pathway
- healthcare
- oxidative stress
- big data
- public health
- cardiovascular disease
- mental health
- reactive oxygen species
- metabolic syndrome
- electronic health record
- adipose tissue
- dna repair
- randomized controlled trial
- machine learning
- protein kinase
- adverse drug
- skeletal muscle